Research Analysts Issue Forecasts for DRUG FY2025 Earnings

Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 EPS estimates for Bright Minds Biosciences in a note issued to investors on Wednesday, July 2nd. Cantor Fitzgerald analyst P. Stavropoul…

Read Full Article →